You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 20207805
Dec 20203206
Jan 20211000
Feb 20211403
Mar 20213205
Apr 2021402
May 2021803
Jun 2021005
Jul 2021004
Aug 2021004
Sep 2021003
Oct 202112018
Nov 20212809
Dec 20211404
Jan 2022900
Feb 20221201
Mar 2022600
Apr 20223203
May 20222801
Jun 2022801
Jul 2022800
Aug 20221403
Sep 20221401
Oct 2022800
Nov 2022401
Dec 20221601
Jan 2023600
Feb 20232201
Mar 2023600
Apr 20231202
May 2023600
Jun 2023200
Jul 2023202
Aug 2023200
Sep 2023601
Oct 2023801
Nov 20231001
Dec 20232800
Jan 2024800
Feb 20241400
Mar 2024601
Apr 20241001
May 20241402
Jun 20241600
Jul 20241601
Aug 20241802
Sep 20241800
Oct 20241203
Nov 2024803
Dec 2024402
Jan 2025405
Feb 2025003
Mar 2025004
Apr 2025004
May 2025004
Jun 2025002
Total6490128